Assertio Therapeutics's total assets for Q1 2025 were $286.43M, an increase of 0.59% from the previous quarter. ASRT total liabilities were $177.90M for the fiscal quarter, a 8.70% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.